Big Pharma Shoves America Off the Wagon

Ryan Goldberg  Jul 09, 2009 1:00 pm

Big Pharma Shoves America Off the Wagon
 
Percentage of people using prescription drugs is staggering.
 

This trend seems to beg the question: Why do so many Americans seek to medicate what seem to be entirely normal emotions? If you were to lose your job, say, or see your net worth reduced by 75%, you could reasonably expect to feel just a wee bit blue.

So why pop a pill?

Advertisements reinforce this idea. Take, for instance, a commercial for Pfizer’s (PFE) Zoloft, in which the voiceover soothingly explains that “it works to correct chemical imbalances in the brain.” There’s a sentence so wonderfully vague, it speaks to just about everybody: Life, after all, is just one big balancing act, isn’t it?

Until recently, psychologists and psychiatrists distinguished depression from clinical depression: The first is a feeling of sadness or melancholy -- the kind you might experience at the death of a parent or the loss of a job; the second is a serious psychological disorder caused by one's neurochemistry.

In a major economic crisis like this one, we'd expect to see a whole lot of the first kind of depression -- and we have, just as we did in previous crises. But the common response to it has been entirely new: Get medicated -- at least if you have health insurance.

The ubiquity of pharmaceutical drugs is a relatively new phenomenon, beginning roughly the 1990s. There are now more than 30 antidepressants from major drug companies. Over 1.8 billion total prescriptions, across drug classes, were written last year.

In the past, psychiatrists had to prescribe psychotropic drugs -- which makes a certain amount of sense. Now, family doctors can scribble at will. And all of these drugs are readily available online with a few clicks and a credit card (along with an appetite for living dangerously).

What anecdotes and statistics from this recession tell us is this: Drugs are being used as a stopgap; there's no larger support program in place. A study of antidepressant use in private health-insurance plans by the New England Research Institute found that 43% of those who had been prescribed antidepressants had no psychiatric diagnosis or any mental-health care beyond the prescription of the drug.

But if you take enough of them -- from Seconal to Ambien to Prozac to horse tranquilizers -- it's kind of hard to care.

Join Hoofy & Boo for a unique look at Big Pharma:


Click Here For Next Article   Watch Hoofy & Boo On The Tax Man Cometh
21 of 41 (51%) found this helpful
Rate this article:  (41 Votes)
Comments (9) See All Comments »
07-10-2009, 8:32 am
The cost of direct to consumer advertising by the Pharm industry adds a huge amount to our outrageous healthcare costs. Doctors believe it is innane, and we and New Zealand are the ONLY two countries permitting it! "Ask your doctor if he
Read More
07-10-2009, 11:23 am
I have been complaining about this insanity for over a decade.

My Sister (a pediatrician) tells me that the pharmacy reps make almost as much as she does, and try and grease her palms with free skybox tickets and other bribes...er...&qu
Read More
07-10-2009, 11:27 am
I forgot to add...

The Levitra advertisement on this page kept popping up as I tried to read the comments!

It has a golf game you can play!?!? Then get your free samples!

Why don't they just hand out the
Read More
07-10-2009, 11:50 am
My sister in law is a drug rep and makes more than some physicians I know. She has a degree in history but is cute and a quick study so when a new product comes out she's off to her doc's with samples and "goodies". Of course
Read More
07-10-2009, 12:58 pm
Finally someone in the press got it right. We don't need lower cost drugs, we need people to take less of them. Like you discuss, there are many, many people who are getting these drugs that really don't need them.

First,
Read More
discuss this article and more on the mv exchange
No positions in stocks mentioned.

Get real-time options trading ideas from Steve Smith, veteran options trader and newsletter author, plus let him show you the way to cut risk and boost your returns through the strategic use of options.  Click here for a free 14 day trial to OptionSmith by Steve Smith.



The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2009 Minyanville Media, Inc. All Rights Reserved.

Ticker Talk
Popular Tickers:
F »AMZN »HIG »
Select
  •  
Talk Now
Share this Talk on your site:
Send us your feedback

Our Professors

rss article alert